RxDx assay as a companion diagnostic to identify c-Met protein expression in non-squamous NSCLC patients eligible for treatment with Emrelis.

Engineers and clinicians working together developed an “optical biopsy” that could improve how kidney disease is diagnosed and studied. The new technology does not rely on stains or dyes. A whole ...